Is there an RTA-GLP-3R dosage chart? Not a validated one — RTA-GLP-3R is investigational, and no amount has been approved for anyone. What researchers actually need at the bench is a concentration chart: how vial size and water volume set the strength of a solution. This page provides that lab reference and explains where published trial designs fit. It is written for researchers working with research-grade RTA-GLP-3R.
For laboratory research use only. Not for human or veterinary use. Investigational and not FDA-approved. The charts below describe solution strength only. They are not usage instructions.
Key takeaways
- There is no approved or validated RTA-GLP-3R dosage chart.
- Lab work relies on a concentration chart: vial size ÷ water volume = mg/mL.
- Published trials used gradual step-up designs under clinical supervision — that is study design, not a chart to follow.
- Exact trial figures are in the published paper, not reproduced here.
RTA-GLP-3R Concentration Chart
Formula: concentration (mg/mL) = peptide in vial (mg) ÷ water added (mL).
| Vial size | Water added | Concentration |
|---|---|---|
| 5 mg | 1 mL | 5 mg/mL |
| 5 mg | 2 mL | 2.5 mg/mL |
| 10 mg | 1 mL | 10 mg/mL |
| 10 mg | 2 mL | 5 mg/mL |
| 10 mg | 4 mL | 2.5 mg/mL |
| 20 mg | 2 mL | 10 mg/mL |
| 20 mg | 4 mL | 5 mg/mL |
- More water = weaker solution. The milligrams in the vial never change.
- Round volumes keep the math simple.
- Full mixing method: RTA-GLP-3R reconstitution.
Volume-to-Amount Reference
Formula: amount (mg) = volume (mL) × concentration (mg/mL).
| Volume | at 10 mg/mL | at 5 mg/mL | at 2.5 mg/mL |
|---|---|---|---|
| 0.01 mL (10 µL) | 0.1 mg | 0.05 mg | 0.025 mg |
| 0.1 mL (100 µL) | 1 mg | 0.5 mg | 0.25 mg |
| 1 mL | 10 mg | 5 mg | 2.5 mg |
This is lab arithmetic only. Record the water volume used — without it, the concentration is unknown.
Where Published Trial Designs Fit
- The main reference is the published Phase 2 trial in NEJM.
- Trials used several study groups and a gradual step-up design to study tolerability.
- Every step was supervised by clinicians, with stopping rules.
- Trials did not use body-weight formulas — see RTA-GLP-3R trial opening levels.
- Full explanation: RTA-GLP-3R trial design explained.
Frequently Asked Questions
Is there an RTA-GLP-3R dosage chart?
No validated chart exists. RTA-GLP-3R is investigational, and no amount is approved. For lab work, researchers use a concentration chart based on vial size and water volume.
How is RTA-GLP-3R concentration calculated?
Concentration (mg/mL) = peptide in vial (mg) ÷ water added (mL). For example, 10 mg in 2 mL gives 5 mg/mL.
Did trials use body-weight-based amounts?
No. Published trials used fixed study groups with gradual step-up designs, not body-weight formulas.
Is RTA-GLP-3R FDA-approved?
No. RTA-GLP-3R is investigational and not FDA-approved. It is sold for laboratory research only.
Research-Grade RTA-GLP-3R
Project Amino supplies RTA-GLP-3R synthesized in the US and third-party lab tested, with a certificate of analysis available per batch. For reconstitution and storage, start from the RTA-GLP-3R research handbook.
Important Regulatory Notice
RTA-GLP-3R sold by Project Amino is a research chemical for laboratory and research use only. It is investigational, not a drug, supplement or medical product, and it is not approved by the FDA. It is not intended for human or veterinary use, or for the diagnosis, treatment, cure or prevention of any disease. All charts describe solution strength for educational purposes only. Purchasers must be 21 or older and are responsible for compliant handling.
